Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ＳＴＩＮＧアゴニストを含むＤＣ－ＳＩＧＮ抗体コンジュゲート
Document Type and Number:
Japanese Patent JP2022509929
Kind Code:
A
Abstract:
本明細書では、ＳＴＩＮＧアゴニストにコンジュゲートされた抗ＤＣ－ＳＩＧＮ抗体を含む免疫複合体が提供される。免疫複合体を作製する方法及び免疫複合体を使用して癌を治療する方法も開示される。

More Like This:
WO/1999/037765HUMAN VANILLOID RECEPTOR HOMOLOGUES
JP2000503659INDUSTRIAL APPLICABILITY Therapeutic application of T-BAM (CD40-L) technology for treating inflammatory renal disease having a starting point other than autoantibody deposition.
WO/2024/049161NOVEL ANTI-PD-L1 CHIMERIC ANTIGEN RECEPTOR, AND IMMUNE CELLS EXPRESSING SAME
Inventors:
Burnett, Lisa
Vendor, stephen
Cho, Charles, Wai.
Cox, sara
Dean, Jonathan
Glacer, Scott, Martin
Hao, Shuesi
Kashibatra, Shiraja
Ou, Weija
Tetsuro Uno
One, Youngkin
Wen, ben
U, Tom, Yao-Hishang
Application Number:
JP2021525182A
Publication Date:
January 25, 2022
Filing Date:
October 30, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Novartis Age
Chinook Therapeutics, Incorporated
International Classes:
C07K16/28; A61K39/395; A61K45/00; A61K47/68; A61P35/00; C12N15/117; C12N15/13
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Iwata Koichi
Yasuhito Suzuki



 
Previous Patent: Health and environment friendly aluminum endothelial paper container and its manufacturing method

Next Patent: Anti-CD73 antibody, its antigen-binding fragment and their use